This site is intended for Healthcare Professionals only.

Swiss competition watchdog probes Novartis over patent use

Date:

Share post:

The Swiss competition commission (COMCO) has opened an investigation of Novartis over possible unlawful use of a patent to reduce competitive pressure, the Swiss drugmaker confirmed on Thursday, September 15.

COMCO conducted an early morning raid on the company on Sept. 13, it said in a statement that did not name Novartis, which subsequently said in its own statement that it was the group under investigation.

“The company allegedly attempted to protect its drug for the treatment of skin diseases against competing products by using one of its patents to initiate litigation proceedings,” COMCO said in a statement.

Novartis said COMCO had started an investigation in collaboration with the European Commission into the assertion of a patent in the broader field of dermatology treatments.

“In connection with this investigation, COMCO representatives visited the company headquarters in Basel,” it said.

“The opening of an investigation does not imply any finding of wrongdoing or any financial impact. Novartis is fully cooperating with the authorities and is confident to clarify the legitimacy of its position,” it added.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

[my_vc_php_output]

Related articles

Ultra-processed foods constitute nearly two-thirds of UK adolescents’ calorie intake, NIHR study finds

Consumption of ultra-processed foods found highest among adolescents from deprived backgrounds, those of white ethnicity and younger adolescents A...

PAGB urges Labour government to prioritise self-care in first 100 days for positive health impact

PAGB says self-care could save NHS £1.7bn by reducing 30 Million unnecessary GP and A&E visits annually and...

Global IT outage: Community pharmacy services disrupted

Services including accessing prescriptions from GPs and medicine deliveries are being disrupted due to global IT outages A massive...

NPA’s Save Our Pharmacies petition surpasses 230,000 signatures

The NPA has announced a second day of action on 19 September as part of its Save Our...